Search research articles
Contact Us
Filters
Showing results (381-390 of 406) with videos related to
Page
of 41
Sort By:
European Journal of Clinical Investigation
|
June 1, 1997
Growth hormone improves cardiac function in rats with experimental myocardial infarction
J Isgaard, V Kujacic, E Jennische, et al.
Cardiovascular Research
|
November 1, 1993
Hypersensitivity of Gi protein mediated muscarinic receptor adenylyl cyclase in chronic ischaemic heart failure in the rat
L X Fu, Q P Feng, Q M Liang, et al.
Blood Pressure
|
October 1, 1992
Radioimmunoassay of endothelin in human plasma
P H Rasmussen, I G Plum, N E Bruun, et al.
Blood Pressure
|
September 1, 1996
The Swedish Trial in old patients with hypertension-2 (STOP-hypertension-2): a progress report
L H Lindholm, L Hansson, B Dahlöf, et al.
Acta Physiologica Scandinavica
|
June 1, 1988
Baroreflex modulation of sympathetic activity and sympathetic neurotransmitters in humans
D L Eckberg, R F Rea, O K Andersson, et al.
Blood Pressure
|
June 1, 1993
STOP-Hypertension 2: a prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Swedish Trial in Old Patients with Hypertension
B Dahlöf, L Hansson, L H Lindholm, et al.
European Journal of Pharmacology
|
November 28, 1996
Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor
A Bergdahl, T Nilsson, L Cantera, et al.
Endocrinology
|
December 30, 1999
The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction
A Tivesten, E Bollano, K Caidahl, et al.
Lakartidningen
|
December 11, 1991
[Ambulatory blood pressure measurement--guidelines for registration and data processing]
U de Faire, B Dahlöf, I Enström, et al.
Lancet (London, England)
|
November 30, 1999
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
L Hansson, L H Lindholm, T Ekbom, et al.
Page
of 41
Search research articles
Search
Showing results (381-390 of 406) with videos related to
Sort By:
Page
of 41
European Journal of Clinical Investigation
|
June 1, 1997
Growth hormone improves cardiac function in rats with experimental myocardial infarction
J Isgaard, V Kujacic, E Jennische, et al.
Cardiovascular Research
|
November 1, 1993
Hypersensitivity of Gi protein mediated muscarinic receptor adenylyl cyclase in chronic ischaemic heart failure in the rat
L X Fu, Q P Feng, Q M Liang, et al.
Blood Pressure
|
October 1, 1992
Radioimmunoassay of endothelin in human plasma
P H Rasmussen, I G Plum, N E Bruun, et al.
Blood Pressure
|
September 1, 1996
The Swedish Trial in old patients with hypertension-2 (STOP-hypertension-2): a progress report
L H Lindholm, L Hansson, B Dahlöf, et al.
Acta Physiologica Scandinavica
|
June 1, 1988
Baroreflex modulation of sympathetic activity and sympathetic neurotransmitters in humans
D L Eckberg, R F Rea, O K Andersson, et al.
Blood Pressure
|
June 1, 1993
STOP-Hypertension 2: a prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Swedish Trial in Old Patients with Hypertension
B Dahlöf, L Hansson, L H Lindholm, et al.
European Journal of Pharmacology
|
November 28, 1996
Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor
A Bergdahl, T Nilsson, L Cantera, et al.
Endocrinology
|
December 30, 1999
The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction
A Tivesten, E Bollano, K Caidahl, et al.
Lakartidningen
|
December 11, 1991
[Ambulatory blood pressure measurement--guidelines for registration and data processing]
U de Faire, B Dahlöf, I Enström, et al.
Lancet (London, England)
|
November 30, 1999
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
L Hansson, L H Lindholm, T Ekbom, et al.
Page
of 41